NR3C1 Modulates Wnt Signalling to Influence the Invasiveness and Immune Features of Nonfunctioning Invasive Pituitary Adenomas
Journal of Cellular and Molecular Medicine · 2026-04 · 30 (7)
DOI: 10.1111/jcmm.71097 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, online erschienen am 29.03.2026. Verfasst von Xiaoping Wang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, The First Affiliated Hospital of Fujian Medical University, Fuzhou City, Fujian Province, China. Hauptthemen laut MEDLINE: Pituitary Neoplasms, Adenoma, Wnt Signaling Pathway, Receptors, Glucocorticoid. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Xiamen Municipal Health and Wellness High-Quality Development Science and Technology Plan Project, 2025 Xiamen Municipal Medical and Health Guidance Project.
Abstract (Originalsprache)
Pituitary adenomas (PAs) are common intracranial tumours, and invasiveness in nonfunctioning invasive pituitary adenomas (NIPAs) predicts poor prognosis. The molecular mechanisms driving this phenotype remain unclear. This study explored the role of nuclear receptor subfamily 3 group C member 1 (NR3C1) in NIPA invasiveness and its regulation of Wnt signalling. mRNA expression profiles of 32 PA samples were generated by RNA‐seq, and proteomic data from 19 samples were obtained by mass spectrometry. Immune‐related differentially expressed genes (DEGs) were retrieved from GeneCards. Weighted gene coexpression network analysis identified modules and hub genes linked to invasiveness, while machine learning methods (support vector machine, LASSO, random forest) prioritised key genes. Gene set enrichment analysis (GSEA) assessed pathways associated with candidate gene expression. NR3C1 expression and function were validated by immunohistochemistry, Western blotting and invasion assays. Integration of transcriptomic, proteomic and immune‐related datasets yielded 11 overlapping genes, with NR3C1 emerging as the top candidate. NR3C1 was significantly upregulated in NIPAs and demonstrated good discriminatory power by ROC analysis. GSEA associated high NR3C1 expression with Wnt pathway activation. Functional experiments confirmed that NR3C1 overexpression enhances the invasive capacity of PA cells. NR3C1 promotes the invasive phenotype of NIPAs by activating Wnt signalling. These findings suggest NR3C1 as a potential biomarker and therapeutic target for invasive pituitary adenomas.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurosurgery, The First Affiliated Hospital of Fujian Medical University, Fuzhou City, Fujian Province, China.
- Department of Neurosurgery, Xiamen Hospital of Traditional Chinese Medicine, Xiamen, Fujian Province, China.
- Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
ORCID-Profile: Yuanxiang Lin
Förderung
- Xiamen Municipal Health and Wellness High-Quality Development Science and Technology Plan Project
- 2025 Xiamen Municipal Medical and Health Guidance Project
Zitieren
APA
Wang, X., Zhang, J., Jiang, T., Yang, Z., Zhang, Y., Liu, P., & Lin, Y. (2026). NR3C1 Modulates Wnt Signalling to Influence the Invasiveness and Immune Features of Nonfunctioning Invasive Pituitary Adenomas. Journal of Cellular and Molecular Medicine, 30(7). https://doi.org/10.1111/jcmm.71097
Vancouver
Wang X, Zhang J, Jiang T, Yang Z, Zhang Y, Liu P, et al. NR3C1 Modulates Wnt Signalling to Influence the Invasiveness and Immune Features of Nonfunctioning Invasive Pituitary Adenomas. Journal of Cellular and Molecular Medicine. 2026;30(7). doi:10.1111/jcmm.71097
BibTeX
@article{Wang2026,
author = {Wang, Xiaoping and Zhang, Jinfeng and Jiang, Tao and Yang, Zhijun and Zhang, Yu and Liu, Pinan and Lin, Yuanxiang},
title = {NR3C1 Modulates Wnt Signalling to Influence the Invasiveness and Immune Features of Nonfunctioning Invasive Pituitary Adenomas},
journal = {Journal of Cellular and Molecular Medicine},
year = {2026},
volume = {30},
number = {7},
doi = {10.1111/jcmm.71097}
}
EUVIMED